摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methoxy-4-methylthiophene

中文名称
——
中文别名
——
英文名称
2-methoxy-4-methylthiophene
英文别名
——
2-methoxy-4-methylthiophene化学式
CAS
——
化学式
C6H8OS
mdl
——
分子量
128.195
InChiKey
BDPVOCHKMZMWKM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    37.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and characterization of non-symmetrical photoswitchable DTE(OMe) sensitizers
    摘要:
    DTE-BODIPY 2 and BTD-DTE 3 were designed for reversible light modulation of electron- and energy-transfer processes on TiO2, and showed almost complete ring closure. In BTD-DTE 3 the BTD is an acceptor group in the open form (OF), and an energy donor group in the closed form (CF), but this property is depending on the solvent. Quantum yields for ring closure decreased (BTD-DTE 3: factor 5; DTE-BODIPY 2: factor 12) compared to DTE 1, because of it-system elongation in OFs, and also cycloreversion quantum yields became smaller (BTD-DTE 3: factor 1.4; DTE-BODIPY 2: factor 2.2). (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2018.05.042
  • 作为产物:
    描述:
    2-溴-4-甲基噻吩sodium methylate 在 copper(I) bromide 作用下, 以 甲醇 为溶剂, 反应 8.0h, 以88%的产率得到2-methoxy-4-methylthiophene
    参考文献:
    名称:
    1,3-双环[1.1.1]戊二基:苯基化的光致变色单元和1,5-二甲氧基-9,10-二(苯基乙炔基)蒽荧光团的最短的刚性线性连接器。
    摘要:
    将过量的1,3-二苯基双环[1.1.1]戊烷碘化,以63%的收率制得的双1,3-(4-碘苯基)双环[1.1.1]戊烷与9-乙炔基-1,5-二甲氧基-10-苯基乙炔基蒽(26),随后带有1-(2-甲基/甲氧基-4-甲基-5-苯基噻吩-3-基)-2-(2-甲基)的锌衍生物/甲氧基-4-甲基噻吩-3-基)全氟环戊烯(38-H-41-H)。区域选择性合成2-未取代的噻吩38-H-41-H需要中间体制备2-三甲基甲硅烷基-3,5-二甲基-4-溴噻吩(37)或2-三甲基甲硅烷基-5-甲氧基-3-甲基-4-溴噻吩(40)。用2-三甲基甲硅烷基保护噻吩环的α-位可阻止4-硫代衍生物重排成相应的2-锂化的噻吩。与双环[1.1。1]戊烷片段连接光致变色单元1-3和1,5-二甲氧基-9,10-二(苯基乙炔基)蒽作为荧光部分,荧光团(供体)的激发态与封闭形式之间的定量共振能量转移观察到了光致变色单元1-3(受体)
    DOI:
    10.1002/chem.200601316
点击查看最新优质反应信息

文献信息

  • NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC
    申请人:Rhizen Pharmaceuticals SA
    公开号:US20150057309A1
    公开(公告)日:2015-02-26
    The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.
    本发明提供了作为c-Met蛋白激酶调节剂有用的化合物,以及制备它们的方法,含有它们的药物组合物,以及使用它们进行治疗、预防和/或改善c-Met激酶介导的疾病或疾病的方法。
  • NOVEL KINASE MODULATORS
    申请人:MUTHUPPALANIAPPAN Meyyappan
    公开号:US20110118257A1
    公开(公告)日:2011-05-19
    The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
    本发明提供了PI3K蛋白激酶调节剂,其制备方法,含有它们的药物组合物,以及使用它们进行激酶介导的疾病或紊乱的治疗、预防和/或改善的方法。
  • NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES
    申请人:MUTHUPPALANIAPPAN Meyyappan
    公开号:US20110281865A1
    公开(公告)日:2011-11-17
    The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
    本发明提供了一种公式I的化合物作为蛋白激酶调节剂,以及它们的制备方法、含有它们的药物组合物,以及利用它们治疗、预防和/或改善激酶介导的疾病或紊乱的方法。
  • NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES
    申请人:NAGARATHNAM Dhanapalan
    公开号:US20120289496A1
    公开(公告)日:2012-11-15
    The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
    本发明提供了PI3K蛋白激酶调节剂,其制备方法,含有它们的药物组合物,以及使用它们进行治疗、预防和/或改善激酶介导的疾病或紊乱的方法。
  • Hydrazone derivatives for combatting harmful insects and arachnids
    申请人:Hofmann Michael
    公开号:US20070066627A1
    公开(公告)日:2007-03-22
    The present invention relates to a method for combating insects or arachnids which comprises contacting the insects or the arachnids, their habitat, breeding ground, food supply, plant, seed, soil, area, material or environment in which the insects or the arachnids are growing or may grow, or the materials, plants, seeds, soils, surfaces or spaces to be protected from insect or arachnid attack or infestation with a pesticidally effective amount of a compound of the general formula (I) or a salt thereof wherein: Ar is a cyclic radical, n is 0 or 1, X is CO or SO 2 and R 1 to R 4 are as defined in claim 1 .
    本发明涉及一种用于对抗昆虫或蜘蛛的方法,包括将昆虫或蜘蛛、它们的栖息地、繁殖场地、食物供应、植物、种子、土壤、区域、材料或环境与通式(I)化合物或其盐的农药有效量接触,其中:Ar为环状基团,n为0或1,X为CO或SO2,R1至R4如权利要求1所定义。
查看更多